Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-06-27
2006-06-27
Davis, Zinna Northington (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S146000
Reexamination Certificate
active
07067529
ABSTRACT:
Compounds of formula I are providedas well as pharmaceutically acceptable salts and esters thereof, wherein the substituents are as disclosed in the specification. The compounds have utility for the treatment of type 2 diabetes mellitus.
REFERENCES:
patent: 4042697 (1977-08-01), Garside et al.
patent: 2.199.462 (1974-04-01), None
patent: 63-310813 (1988-12-01), None
patent: WO 01/55117 (2001-08-01), None
Postaire et al, Bulletin de la Societe Chimique de France, vol. 6, p. 982-988, 1988.
Reen-Yen Kuo et al, Bioorganic & Medicinal Chemistry Letters, vol. 13, No. 16, pp. 2789-2793 (XP-002302935) (2003).
Almudena Bermejo et al, Journal of Medicinal Chemistry, vol. 45, No. 23, pp. 5058-5068 (XP002302936) (2002).
Anselmi, Else, et. al., “Selective inhibition of calcium entry induced by benzylisoquinolines in rat smooth muscle”, J. Pharm. Pharmacol. (1992) 44(4), 337-343.
M.A. Badet-Denisot, et. al., Bioorg. Med. Chem. Letters, 5, 815-820 (1995).
S.L. Bearne, J. Biol. Chem., 271, 3052-3057 (1996).
S.L. Bearne, et. al., Biochem., 34, 11515-11520 (1995).
F. Bister-Miel, et. al., Plantes Medicinales et Phytotherapie (1986), Tome XX, N°1, p. 3-7.
Chen Chen, et. al., J. Med. Chem. (2001) 44, 4001-4010.
H. Chmara, J. Gen. Microbiol., 131, 265-271 (1985).
Markwardt, Fritz, et. al., “Influence of 6,7-dimethoxyisoquinoline derivatives on the function of thrombocytes” Acta Biologica et Medica Germanica (1969) 23(2), 295-306.
F. Massiere, et. al., J. Amer. Chem., Soc., 119, 5748-5749 (1997).
S. Milewski, et. al., Biochim. Biophys. Acta, 1115, 225-229 (1992).
E. Postaire, et. al., Ann. Pharmaceutiques Francaises (1985), 43, n°6, pp. 547-556.
D. Walterova, et. al., Collective Czechoslov. Chem. Commun, (1980), 45, pp. 956-965.
Bolin David Robert
Chen Shoaqing
Mischke Steven Gregory
Qian Yimin
Davis Zinna Northington
Hoffmann-La Roche Inc.
Johnston George W.
Megerditchian Samuel H.
Tramaloni Dennis P.
LandOfFree
Glutamine fructose-y-phosphate amidotransferase (GFAT)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glutamine fructose-y-phosphate amidotransferase (GFAT)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glutamine fructose-y-phosphate amidotransferase (GFAT)... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3618616